PLA2G4E and Alzheimer disease: Furthermore, increased PLA2G4E has also been demonstrated in the temporal cortex of cognitively intact patients with AD pathology (Braak II-IV) and in control donors compared to AD patients (Braak V-VI), while upregulation restored cognitive deficits in APP/PS1 animals and increased spine density.